[go: up one dir, main page]

DK1263759T3 - Azainodoler - Google Patents

Azainodoler

Info

Publication number
DK1263759T3
DK1263759T3 DK00985695.6T DK00985695T DK1263759T3 DK 1263759 T3 DK1263759 T3 DK 1263759T3 DK 00985695 T DK00985695 T DK 00985695T DK 1263759 T3 DK1263759 T3 DK 1263759T3
Authority
DK
Denmark
Prior art keywords
ny3y4
compounds
halo
heteroaryl
cyano
Prior art date
Application number
DK00985695.6T
Other languages
English (en)
Inventor
Paul Joseph Cox
Tahir Nadeem Majid
Justine Yeun Qua Lai
Andrew David Morley
Shelley Amendola
Stephanie Deprets
Chris Edlin
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Priority claimed from PCT/GB2000/004993 external-priority patent/WO2001047922A2/en
Application granted granted Critical
Publication of DK1263759T3 publication Critical patent/DK1263759T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00985695.6T 1999-12-24 2000-12-27 Azainodoler DK1263759T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9930698.7A GB9930698D0 (en) 1999-12-24 1999-12-24 Chemical compounds
US21581800P 2000-07-05 2000-07-05
PCT/GB2000/004993 WO2001047922A2 (en) 1999-12-24 2000-12-27 Azaindoles

Publications (1)

Publication Number Publication Date
DK1263759T3 true DK1263759T3 (da) 2011-01-10

Family

ID=10867079

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00985695.6T DK1263759T3 (da) 1999-12-24 2000-12-27 Azainodoler
DK08162392.8T DK1990343T3 (da) 1999-12-24 2000-12-27 Azaindoler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK08162392.8T DK1990343T3 (da) 1999-12-24 2000-12-27 Azaindoler

Country Status (12)

Country Link
JP (1) JP4871474B2 (da)
AT (2) ATE480537T1 (da)
DE (1) DE60044946D1 (da)
DK (2) DK1263759T3 (da)
ES (2) ES2382759T3 (da)
GB (1) GB9930698D0 (da)
ME (1) MEP49908A (da)
PL (1) PL218884B1 (da)
PT (2) PT1263759E (da)
RS (2) RS51303B (da)
UA (1) UA76410C2 (da)
ZA (1) ZA200204126B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422057D0 (en) * 2004-10-05 2004-11-03 Astrazeneca Ab Novel compounds
SI1962830T1 (sl) * 2005-12-23 2013-07-31 Glaxosmithkline Llc Azaindolni inhibitorji kinaz Aurora
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
JP5274805B2 (ja) * 2006-09-20 2013-08-28 三菱化学株式会社 フッ素化芳香族化合物の製造方法
EP2373653B1 (en) * 2008-12-05 2014-04-02 F. Hoffmann-La Roche AG Pyrrolopyrazinyl urea kinase inhibitors
EP2470531A1 (en) * 2009-08-26 2012-07-04 Nycomed GmbH Methylpyrrolopyridinecarboxamides
JP2016514113A (ja) * 2013-03-14 2016-05-19 アッヴィ・インコーポレイテッド ピロロ[2,3−b]ピリジンcdk9キナーゼ阻害剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0948495T3 (da) * 1996-11-19 2004-06-01 Amgen Inc Aryl- og heteroarylsubstitueret, kondenseret pyrrol som antiinflammatoriske midler
WO1998047899A1 (en) * 1997-04-24 1998-10-29 Ortho-Mcneil Corporation, Inc. Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
PL340412A1 (en) * 1997-10-20 2001-01-29 Hoffmann La Roche Bicyclic kinase inhibitors

Also Published As

Publication number Publication date
ES2382759T3 (es) 2012-06-13
JP4871474B2 (ja) 2012-02-08
GB9930698D0 (en) 2000-02-16
PT1263759E (pt) 2010-11-02
PT1990343E (pt) 2012-05-22
PL218884B1 (pl) 2015-02-27
ZA200204126B (en) 2003-08-25
MEP49908A (en) 2011-02-10
ATE480537T1 (de) 2010-09-15
ATE552258T1 (de) 2012-04-15
RS51303B (sr) 2010-12-31
DE60044946D1 (de) 2010-10-21
YU46202A (sh) 2005-06-10
DK1990343T3 (da) 2012-07-23
JP2003519144A (ja) 2003-06-17
ES2348861T3 (es) 2010-12-16
UA76410C2 (en) 2006-08-15
RS20100123A (sr) 2010-12-31

Similar Documents

Publication Publication Date Title
AP1587A (en) Azaindoles.
RU2500680C2 (ru) Новые замещенные пиридин-2-оны и пиридазин-3-оны
ES2121441T3 (es) Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco
HUP0400247A2 (hu) Azaindolok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
BR0309710A (pt) Composição ácida espessada e usos da mesma
MY153023A (en) Tropane derivatives useful in therapy
TW200612920A (en) Novel imidazolidine derivatives
TR200101711T2 (tr) Antihistaminik spiro bileşikler.
DK1263759T3 (da) Azainodoler
EA200500122A1 (ru) Новые соединения, фармацевтические композиции, содержащие их, и способы их использования
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
SE9001269D0 (sv) 2-substituted n,n-ditrimethoxybenzoyl piperazines,a preparation process of the same and therapeutic compositions containing them
GB0119863D0 (en) DNA-PK inhibitors
EA200400470A1 (ru) Замещенные производные алкиламинопиридазинона, способ их получения и содержащие их фармацевтические композиции
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
MY123373A (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
DE60119383D1 (de) Farnesyltransferasehemmende 4-heterocyclylchinolin- und chinazolinderivate
MXPA04003741A (es) Derivados novedosos de hidroxialquil indolocarbazol, metodo de preparacion y composiciones farmaceuticas que los contienen.
BG106613A (en) Phenyl-and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
DE60026161D1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten
NO20035026D0 (no) Dihydroimidazo [5,1-A]-<beta>-karbolinderivater, fremgangsmåte til deres fremstilling og anvendelse derav som legemiddel
DE69828087D1 (de) Aminderivate
ATE434615T1 (de) Farnesyltransferase hemmende benzoheterocyclische derivate
GB0114699D0 (en) Organic compounds
GB1016652A (en) Quaternary ammonium compounds and methods for making same